FOLD Q3 2022 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$82M+2.7% YoY

Gross Profit

$68M83.6% margin

Operating Income

-$34M-41.4% margin

Net Income

-$33M-40.7% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$11M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$760M

Total Liabilities

$627M

Stockholders' Equity

$133M

Cash & Equivalents

$278M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$80M	+2.7%
Gross Profit	$68M	$68M	+0.6%
Operating Income	-$34M	-$42M	+20.2%
Net Income	-$33M	-$50M	+33.8%

Geographic Segments

Non-US

$51M63%

UNITED STATES

$30M37%